Market Research Logo

Global Lung Cancer Therapeutics Market 2019-2023

Global Lung Cancer Therapeutics Market 2019-2023

About this market

The global lung cancer therapeutics market has witnessed significant growth in recent years, primarily due to the increasing approval of immunomodulators. Vendors are conducting research on various types of cancer using these therapies. The market currently has only a limited number of checkpoint inhibitors, but these drugs contribute significantly to the global lung cancer therapeutics market. The high proven efficacy and the increasing popularity of these drugs are expected to contribute significantly to the growth of the global lung cancer therapeutics market during the forecast period. Technavio’s analysts have predicted that the lung cancer therapeutics market will register a CAGR of about 13% by 2023.

Market Overview

Strong prevalence of lung cancer

Lung cancer is one of the most common cancer types. It is also the most common cause of cancer-related deaths globally. The new cases of cancer, especially lung cancer, have increased significantly in recent years, owing to factors such as the increasing geriatric population and lifestyle changes.

Adherence to available alternatives

The increasing advances in the diagnostic methods for lung cancer. These advances are leading to the early detection of lung cancer and are resulting in the increasing use of surgeries and radiation therapy for the treatment of the disease. This is expected to reduce the scope of therapeutics for the treatment of lung cancer, thus reducing patient adherence to lung cancer therapeutics. Thus, the increasing patient adherence to the available alternatives is expected to limit the growth of the global lung cancer therapeutics market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the lung cancer therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global oncology therapeutics market
      • Table Segments of global oncology therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Pipeline
    • Table Global lung cancer therapeutics market pipeline: Overview
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • NSCLC - Market size and forecast 2018-2023
      • Table NSCLC - Market size and forecast 2018-2023 ($ millions)
      • Table NSCLC - Year-over-year growth 2019-2023 (%)
    • SCLC - Market size and forecast 2018-2023
      • Table SCLC - Market size and forecast 2018-2023 ($ millions)
      • Table SCLC - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table New cases and mortality rates of lung cancer in 2008
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Company
      • Table Bristol-Myers Squibb Company - Vendor overview
      • Table Bristol-Myers Squibb Company - Business segments
      • Table Bristol-Myers Squibb Company - Organizational developments
      • Table Bristol-Myers Squibb Company - Geographic focus
      • Table Bristol-Myers Squibb Company - Key offerings
      • Table Bristol-Myers Squibb Company - Key customers
    • F. Hoffmann-La Roche Ltd
      • Table F. Hoffmann-La Roche Ltd - Vendor overview
      • Table F. Hoffmann-La Roche Ltd - Business segments
      • Table F. Hoffmann-La Roche Ltd - Organizational developments
      • Table F. Hoffmann-La Roche Ltd - Geographic focus
      • Table F. Hoffmann-La Roche Ltd - Segment focus
      • Table F. Hoffmann-La Roche Ltd - Key offerings
      • Table F. Hoffmann-La Roche Ltd - Key customers
    • Merck & Co., Inc.
      • Table Merck & Co., Inc. - Vendor overview
      • Table Merck & Co., Inc. - Business segments
      • Table Merck & Co., Inc. - Organizational developments
      • Table Merck & Co., Inc. - Geographic focus
      • Table Merck & Co., Inc. - Segment focus
      • Table Merck & Co., Inc. - Key offerings
      • Table Merck & Co., Inc. - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report